Maryam Abdul-Kareem

Maryam joined Arcellx as the General Counsel in June 2022. Most recently, she served as Deputy General Counsel at Kinnate Biopharma Inc. Prior to Kinnate, she was Assistant General Counsel, Corporate at AstraZeneca Pharmaceuticals LP, where she led negotiations for numerous complex strategic transactions, including a landmark license deal with the University of Oxford for global rights to the ChAdOx1 COVID-19 vaccine. Previously, Maryam held the position of Associate, Corporate & Securities at Pepper Hamilton LLP (now Troutman Pepper). She began her career as Study Technician/Assistant Toxicologist, Genetic Toxicology at Covance Labs Inc. (now Labcorp); and Clinical Marketing Specialist, Global Marketing at Given Imaging Ltd. (now Medtronic). Maryam holds a JD from Georgetown University Law Center, an MS in Biotechnology/Regulatory Affairs from Johns Hopkins University, and a BS in Laboratory Animal Science from North Carolina Agricultural and Technical State University. She is an attorney licensed by the Supreme Court of Pennsylvania and registered with the State Bar of California.